Carla Lombardo

ORCID: 0009-0005-5162-6091
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Food Allergy and Anaphylaxis Research
  • Drug-Induced Adverse Reactions
  • Urticaria and Related Conditions
  • Contact Dermatitis and Allergies
  • Allergic Rhinitis and Sensitization
  • Asthma and respiratory diseases
  • Mast cells and histamine
  • Dermatology and Skin Diseases
  • Eosinophilic Esophagitis
  • Celiac Disease Research and Management
  • Immune Response and Inflammation
  • Burn Injury Management and Outcomes
  • Immunotherapy and Immune Responses
  • Respiratory and Cough-Related Research
  • Microscopic Colitis
  • Thermoregulation and physiological responses
  • Immune Cell Function and Interaction
  • Occupational exposure and asthma
  • Thermal Regulation in Medicine
  • Sinusitis and nasal conditions
  • Inflammatory mediators and NSAID effects
  • Pharmaceutical studies and practices
  • Diverse Scientific and Economic Studies
  • Entomological Studies and Ecology
  • Fibromyalgia and Chronic Fatigue Syndrome Research

Provincia Autonoma di Trento
2023

Ospedale Santa Chiara
2019-2022

Interventi Geo Ambientali (Italy)
2022

University of Verona
2011-2016

Zero to Three
2016

Ospedale di Santo Spirito
2016

Azienda Ospedaliera Universitaria Integrata Verona
2014-2015

Brigham and Women's Hospital
2015

University of Michigan
2015

Pfizer (United States)
2015

Abstract Skin tests are of paramount importance for the evaluation drug hypersensitivity reactions. Drug skin often not carried out because lack concise information on specific test concentrations. The diagnosis allergy is based history alone, which an unreliable indicator true hypersensitivity.To promote and standardize reproducible testing with safe nonirritant concentrations in clinical practice, E uropean N etwork A cademy llergy C linical I mmunology ( EAACI ) Interest Group Allergy has...

10.1111/all.12142 article EN Allergy 2013-04-25

Anaphylaxis, which is rare, has been reported after COVID-19 vaccination, but its management not standardized.Members of the European Network for Drug Allergy and Academy Clinical Immunology interested in drug allergy participated an online questionnaire on pre-vaccination screening allergic reactions to vaccines, literature was analysed.No death due anaphylaxis vaccines confirmed scientific literature. Potential allergens, polyethylene glycol (PEG), polysorbate tromethamine are excipients....

10.1111/all.15241 article EN Allergy 2022-02-03

Abstract Background Biologics are currently one of the main treatment options for a number diseases. The IgG4 monoclonal antibody dupilumab targets Interleukin-4 receptor alpha chain, thus preventing biological effects cytokines IL-4 and IL-13, that essential Th2 response. Several controlled trials showed is effective safe in patients with atopic dermatitis (AD), severe asthma chronic rhinosinusitis nasal polyps (CRSwNP), resulting approval by regulatory agencies. Aim study was to evaluate...

10.1186/s12948-022-00171-2 article EN cc-by Clinical and Molecular Allergy 2022-05-19

Background Hypersensitivity to acetylsalicylic acid (ASA) constitutes a serious problem for subjects with coronary artery disease. In such subjects, physicians have choose the more appropriate procedure between challenge and desensitization. As literature on this issue is sparse, study aimed establish in these clinical criteria eligibility an ASA and/or Methods Collection analysis of data challenges desensitizations from 10 allergy centers, as well consensus among related expert panel....

10.1111/all.13068 article EN Allergy 2016-10-13

Abstract Background Dupilumab is an anti‐IL‐4Rα antibody used in the treatment of patients with moderate‐to‐severe atopic dermatitis (msAD). This study explored potential benefit dupilumab perennial allergic rhinoconjunctivitis (PAR) and asthma (PAA) caused by indoor allergens adults msAD. Methods multicentric, prospective, observational, real‐life included adult msAD who had been treated 16 Italian care centres. Efficacy outcomes regarding AD, PAR PAA were collected at baseline weeks....

10.1111/all.14338 article EN Allergy 2020-04-24

Cross-reactivity between aztreonam and penicillins is poor, but clinical tolerance of has been assessed, by means challenge tests, only in a few groups penicillin-allergic patients. The aim this study to evaluate the tolerability large group beta-lactam-allergic We studied all patients (greater than 14 years age), with history immediate reactions any beta-lactam positive immediate-type skin tests and/or specific IgE beta-lactam; they were of: prick intradermal penicilloyl polylysine, minor...

10.1177/039463200802100215 article EN International Journal of Immunopathology and Pharmacology 2008-04-01

<i>Background:</i> Cross-reactivity between aztreonam and β-lactams is poor, but tolerability of has been assessed in a few groups patients suffering from IgE-mediated allergy to β-lactams. The aim this study was assess the cross-reactivity with other its cell-mediated these drugs. <i>Methods:</i> We studied 78 who underwent skin prick, immediate delayed-reading intradermal tests as well patch penicilloyl-polylysine, minor determinant mixture, semi-synthetic...

10.1159/000318844 article EN International Archives of Allergy and Immunology 2010-12-21
Coming Soon ...